NAM
ASTH icon

NorthCrest Asset Manangement’s Astrana Health ASTH Stock Holding History

NorthCrest Asset Manangement’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.72M Buy
159,495
+137,598
+628% +$5.43M 0.13% 137
2026
Q2 		$1.02M Buy
+21,897
New +$788K 0.03% 369
2026
Q1 		– Sell
-450,465
Closed -$12.3M – 880
2025
Q4 		$12.3M Buy
450,465
+2,084
+0.5% +$55.3K 0.28% 96
2025
Q3 		$13.6M Sell
448,381
-521
-0.1% -$14.1K 0.32% 90
2025
Q2 		$11.3M Sell
448,902
-10
-0% -$282 0.31% 90
2025
Q1 		$13.9M Buy
448,912
+10
+0% +$333 0.42% 75
2024
Q4 		$14.2M Sell
448,902
-11,993
-3% -$570K 0.42% 70
2024
Q3 		$26.7M Buy
460,895
+262,332
+132% +$12.9M 0.81% 28
2024
Q2 		$8.05M Sell
198,563
-5,000
-2% -$198K 0.27% 99
2024
Q1 		$8.55M Sell
203,563
-20
-0% -$780 0.29% 100
2023
Q4 		$7.8M Buy
203,583
+3,678
+2% +$122K 0.3% 104
2023
Q3 		$6.17M Sell
199,905
-26
-0% -$897 0.25% 116
2023
Q2 		$6.32M Hold
199,931
– – 0.25% 118
2023
Q1 		$7.29M Buy
+199,931
New +$7M 0.3% 107

Other funds holding ASTH

IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
TC
Trust Company Manhattan, Kansas $1.15B AUM 7.83% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
DCM
Davis Capital Management Jacksonville, Florida $167M AUM 17.17% 1-Year Est. Return

NorthCrest Asset Manangement's ASTH Position: Q3 2026 in Review

NorthCrest Asset Manangement increased its Astrana Health (ASTH) stake by 628% in Q3 2026, buying an estimated $5.43M and bringing the position to 159,495 shares worth $5.72M. The position accounts for 0.13% of the portfolio, ranked #137.

NorthCrest Asset Manangement first reported a position in ASTH in Q1 2023 and has held it in 14 quarters since. The position peaked at $26.7M in Q3 2024. 11 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • NorthCrest Asset Manangement held 159,495 shares of Astrana Health worth $5.72M as of Q3 2026.
  • NorthCrest Asset Manangement bought 137,598 Astrana Health shares in Q3 2026, an estimated $5.43M.
  • Astrana Health made up 0.13% of NorthCrest Asset Manangement's portfolio in Q3 2026, its #137 holding.
  • NorthCrest Asset Manangement first reported a position in Astrana Health in Q1 2023 and has held it in 14 quarters since.
  • NorthCrest Asset Manangement's Astrana Health position peaked at $26.7M in Q3 2024.
  • 11 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on NorthCrest Asset Manangement's 13F filing for Q3 2026, filed 13 Oct 2026.